5 天
GlobalData on MSNCStone doses first subject in trial of CS2009 for advanced solid tumoursThe antibody has shown promising results in preclinical studies, demonstrating 'superior' anti-tumour activity.
A recent study revealed that most γδ T cells resident in pre-malignant or non-tumor colon tissues host a cytotoxic signature, while the γδ T cells infiltrated ... then shape early adaptive immune ...
DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...
ImmunoGenesis doses 1st patient in phase 1/2 trial of IMGS-101 in combo with balstilimab & zalifrelimab to treat immune-excluded tumours: Houston Saturday, March 8, 2025, 18:00 Hr ...
As noted above, stellate cell activation is the central event in hepatic fibrosis. Activation consists of 2 major phases: (1) initiation (also called apreinflammatory stage) and (2) perpetuation ...
Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in ... How Healthy Stem Cells Turn Into Or ...
Welcome to the CytomX Therapeutics fourth-quarter 2024 and financial results call. Please be advised that today's call is being recorded. I would now like to hand the call over to your host for today, ...
Q4 2024 Earnings Call Transcript March 6, 2025 CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.22, ...
In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ... Damaged but Not Defeated: Bacteria Use Nano-Spearguns to Retaliate Against Attacks Mar.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果